BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
314 results:

  • 1. Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation.
    Xu W; Chen S; Wang X; Min J; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    BMC Complement Med Ther; 2024 May; 24(1):186. PubMed ID: 38734604
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
    Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
    Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype.
    Muto R; Miyoshi H; Nakashima K; Takeuchi M; Hamasaki M; Ohshima K
    Cancer Med; 2024 Mar; 13(6):e7050. PubMed ID: 38506241
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia.
    Kelesoglu N; Kori M; Yilmaz BK; Duru OA; Arga KY
    Cancer Med; 2023 Dec; 12(24):22420-22436. PubMed ID: 38069522
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models.
    Abboud R; Kim S; Staser K; Jayasinghe RG; Lim S; Amatya P; Frye CC; Kopecky B; Ritchey J; Gao F; Lavine K; Kreisel D; DiPersio JF; Choi J
    Front Immunol; 2023; 14():1264496. PubMed ID: 37744381
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CD4+ T-Cell Subsets in Aplastic Anemia, Myelodysplastic Syndrome, and Acute Myelogenous leukemia Patients: a Comparative Analysis.
    Feng X; Xu H; Yin L; Yin D; Jiang Y
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436393
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Treg Cells,
    Wang SL; Dong QF; Li F; Wang J; Sang YQ; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):666-670. PubMed ID: 37356924
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in foxp3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic leukemia.
    Roškar Z; Dreisinger M; Tič P; Homšak E; Bevc S; Goropevšek A
    Biosensors (Basel); 2023 May; 13(5):. PubMed ID: 37232900
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mocravimod, a S1P receptor modulator, increases T cell counts in bone marrow biopsies from patients undergoing allogeneic hematopoietic stem cell transplantation.
    Dertschnig S; Passweg J; Bucher C; Medinger M; Tzankov A
    Cell Immunol; 2023 Jul; 388-389():104719. PubMed ID: 37141843
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical significance of foxp3 mRNA expression in patients with B chronic lymphocytic leukemia: A preliminary study.
    Elmaraghy N; Ibrahim GA; Elbahahie HE; Emad R
    Egypt J Immunol; 2023 Apr; 30(2):131-140. PubMed ID: 37031415
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation.
    Nishiyama N; Ruoff P; Jimenez JC; Miwakeichi F; Nishiyama Y; Yata T
    Biosystems; 2023 May; 227-228():104889. PubMed ID: 37019377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell leukemia/Lymphoma.
    Tamaki T; Karube K; Sakihama S; Tsuruta Y; Awazawa R; Hayashi M; Nakada N; Matsumoto H; Yagi N; Ohshiro K; Nakazato I; Kitamura S; Nishi Y; Miyagi T; Yamaguchi S; Nakachi S; Morishima S; Masuzaki H; Takahashi K; Fukushima T; Wada N
    Mod Pathol; 2023 Aug; 36(8):100169. PubMed ID: 36997002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic leukemia progression.
    Mékinian A; Quinquenel A; Belkacem KA; Kanoun F; Dondi E; Franck E; Boubaya M; Mhibik M; Baran-Marszak F; Letestu R; Ajchenbaum-Cymbalista F; Lévy V; Varin-Blank N; Le Roy C
    Cancer Gene Ther; 2023 Jul; 30(7):1018-1028. PubMed ID: 36973425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Overexpression of Potential Markers of Regulatory and Exhausted CD8
    Naghavi Alhosseini M; Palazzo M; Cari L; Ronchetti S; Migliorati G; Nocentini G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901957
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors.
    Barreras H; Copsel SN; Bader CS; Ding Y; Wolf D; Cash C; Stacey CJ; Benjamin C; Seavey MM; Wolf J; Jasuja RR; Pfeiffer B; Hill GR; Komanduri KV; Jurecic R; Malek TR; Levy RB
    Transplant Cell Ther; 2023 May; 29(5):341.e1-341.e9. PubMed ID: 36804930
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia.
    Massei MS; Capolsini I; Mastrodicasa E; Perruccio K; Arcioni F; Cerri C; Gurdo G; Sciabolacci S; Falzetti F; Zei T; Iacucci Ostini R; Brogna M; Panizza BM; Saldi S; Merluzzi M; Tognellini R; Marchesi M; Minelli O; Aristei C; Velardi A; Pierini A; Ruggeri L; Martelli MF; Carotti A; Caniglia M
    Bone Marrow Transplant; 2023 May; 58(5):526-533. PubMed ID: 36774432
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
    Penter L; Liu Y; Wolff JO; Yang L; Taing L; Jhaveri A; Southard J; Patel M; Cullen NM; Pfaff KL; Cieri N; Oliveira G; Kim-Schulze S; Ranasinghe S; Leonard R; Robertson T; Morgan EA; Chen HX; Song MH; Thurin M; Li S; Rodig SJ; Cibulskis C; Gabriel S; Bachireddy P; Ritz J; Streicher H; Neuberg DS; Hodi FS; Davids MS; Gnjatic S; Livak KJ; Altreuter J; Michor F; Soiffer RJ; Garcia JS; Wu CJ
    Blood; 2023 Apr; 141(15):1817-1830. PubMed ID: 36706355
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Assessment of regulatory T cells (Tregs) and foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy.
    Sabir SF; Matti BF; Alwatar WMA
    Immunogenetics; 2023 Apr; 75(2):145-153. PubMed ID: 36567345
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma.
    Aguilar C; Beltran BE; Morales D; Gutiérrez-Garibay M; Villela L; Marques-Piubelli ML; Vega F; Miranda RN; Malpica L
    Cardiovasc Pathol; 2023; 64():107513. PubMed ID: 36567046
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.